Results 91 to 100 of about 6,549 (182)

The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis

Current Oncology
Aim: To meta-analyze the utility of transarterial radioembolization (TARE) in patients with liver metastatic breast cancer (BC), based on the objective response rate (ORR) and disease control rate (DCR).
Natale Quartuccio, Vincenzo Militano, Marco Pappalardo, Luca Filippi, Oreste Bagni, Antonino Maria Moreci, Salvatore Ialuna   +6 more
doaj   +1 more source

Advances in Radioembolization for Liver Cancer

Journal of Vascular and Interventional Radiology
Radioembolization, most commonly in the form of transarterial delivery of microspheres embedded or loaded with yttrium-90, has evolved to become a highly effective and versatile treatment modality for both primary and metastatic liver cancers. Refinements in patient selection and dosimetry have advanced this therapy as a frontline choice in many ...
Sam Meiselman, M. Allan Thomas, J. Daniel Giardina, Alexander Zheleznyak, Daniel L.J. Thorek, Christopher D. Malone   +5 more
openaire   +2 more sources

Toward Digital Twins for Optimal Radioembolization

PET Clinics
Radioembolization is a localized liver cancer treatment that delivers radioactive microspheres (30 micron) to tumors via a catheter inserted in the hepatic arterial tree. The goal is to maximize therapeutic efficacy while minimizing damage to healthy liver tissue.
Nisanth Kumar Panneerselvam, Guneet Mummaneni, Emilie Roncali   +2 more
openaire   +3 more sources

Rapid predictive dosimetry for radioembolization.

Asia Oceania journal of nuclear medicine & biology
Economics of today's busy clinical practice demand both time and cost-efficient methods of predictive dosimetry for liver radioembolisation. A rapid predictive schema adapted from the Medical Internal Radiation Dose (MIRD) method i.e., Partition Model, has been devised that can be completed within minutes.
openaire   +3 more sources

Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma

The Saudi Journal of Gastroenterology, 2008
A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for curative treatment in form of resection or transplantation. There are different treatment options for unresectable HCC-like local ablative therapies and recently ...
Al-Kalbani Abdullah, Kamel Yasser
doaj  

A comprehensive review on the current applications and future perspectives of radioembolization in endovascular neurosurgery. [PDF]

J Neurointerv Surg
Liu XYE, Rutka J, Cheng HM, Spears J, Das S, Mendes Pereira V.   +5 more
europepmc   +1 more source

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma. [PDF]

Korean J Radiol
Huang PH, Ou HY, Tsang LC, Hsu HW, Lim WX, Huang TL, Weng CC, Lu Y, Hsu CC, Chen CL, Yu CY, Cheng YF.   +11 more
europepmc   +1 more source

Combination Immunotherapy and Yttrium-90 Radioembolization in Hepatocellular Carcinoma: Biological Rationale, Clinical Evidence, and Future Directions. [PDF]

Cancers (Basel)
Lee EW, Nagra R.
europepmc   +1 more source

Role of Interventional Oncology in the Management of Neuroendocrine Tumors: 2026 Update. [PDF]

Curr Oncol Rep
DePietro DM, Soulen MC.
europepmc   +1 more source

Transarterial Radioembolization [PDF]

, 2020
openaire   +1 more source